Chronix Biomedical today reported that a new study in a peer-reviewed journal further confirms the potential diagnostic and prognostic utility of using circulating fragments of DNA to detect early stage disease. These DNA fragments, referred to as serum DNA, are released into the blood stream in trace amounts during the disease process.

Transasia Bio-Medicals Ltd., leader in the clinical diagnostic segment, has launched the EM 200 – a fully automated clinical chemistry analyser. This instrument offers a complete solution by catering to the Biochemist’s need of work flow management, ease of operation and full automation.

University of Utah scientists successfully created a sensitive prototype device that could test for dozens or even hundreds of diseases simultaneously by acting like a credit card-swipe machine to scan a card loaded with microscopic blood, saliva or urine samples.

If you have ever marveled over the orderly process by which cars, buses and other modes of transportation are directed toward their destinations in a big city, you’ll really appreciate the work of one Florida State University chemist.